Ancora Advisors’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-75
| Closed | -$814 | – | 1847 |
|
|
2024
Q2 | $814 | Hold |
75
| – | – | ﹤0.01% | 1628 |
|
|
2024
Q1 | $1.41K | Hold |
75
| – | – | ﹤0.01% | 1549 |
|
|
2023
Q4 | $1.63K | Sell |
75
-100
| -57% | -$2.17K | ﹤0.01% | 1459 |
|
|
2023
Q3 | $3.6K | Hold |
175
| – | – | ﹤0.01% | 1393 |
|
|
2023
Q2 | $8.23K | Hold |
175
| – | – | ﹤0.01% | 1283 |
|
|
2023
Q1 | $7.34K | Sell |
175
-10
| -5% | -$420 | ﹤0.01% | 1306 |
|
|
2022
Q4 | $7K | Hold |
185
| – | – | ﹤0.01% | 1387 |
|
|
2022
Q3 | $7K | Buy |
185
+10
| +6% | +$378 | ﹤0.01% | 1540 |
|
|
2022
Q2 | $5K | Sell |
175
-19
| -10% | -$543 | ﹤0.01% | 1715 |
|
|
2022
Q1 | $6K | Buy |
194
+19
| +11% | +$588 | ﹤0.01% | 1870 |
|
|
2021
Q4 | $7K | Hold |
175
| – | – | ﹤0.01% | 1921 |
|
|
2021
Q3 | $7K | Hold |
175
| – | – | ﹤0.01% | 1788 |
|
|
2021
Q2 | $10K | Hold |
175
| – | – | ﹤0.01% | 1505 |
|
|
2021
Q1 | $13K | Hold |
175
| – | – | ﹤0.01% | 1366 |
|
|
2020
Q4 | $15K | Hold |
175
| – | – | ﹤0.01% | 1100 |
|
|
2020
Q3 | $11K | Hold |
175
| – | – | ﹤0.01% | 1100 |
|
|
2020
Q2 | $7K | Hold |
175
| – | – | ﹤0.01% | 1132 |
|
|
2020
Q1 | $5K | Sell |
175
-30
| -15% | -$857 | ﹤0.01% | 1232 |
|
|
2019
Q4 | $15K | Buy |
+205
| New | +$15K | ﹤0.01% | 1092 |
|